|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 459.85 INR | -0.77% |
|
+0.98% | +3.74% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 217M 190M 174M 163M 308M 313M 2.1B 813M 10.14B 816M 798M 34.95B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 256M 224M 206M 192M 363M 369M 2.47B 959M 11.96B 962M 941M 41.21B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.20% | ||
| 1 week | +0.98% | ||
| Current month | -1.41% | ||
| 1 month | +22.85% | ||
| 3 months | +52.57% | ||
| 6 months | +5.48% | ||
| Current year | +3.74% |
| 1 week | 427.3 |  | 487.15 |
| 1 month | 353.5 | | 515.55 |
| Current year | 280 | | 515.55 |
| 1 year | 280 | | 656.85 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | +0.98% | -21.68% | +19.87% | 343M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| +3.15% | -1.94% | +26.41% | +20.22% | 339B | |
| -0.29% | +1.37% | +42.24% | +39.91% | 301B | |
| -0.04% | +1.46% | +32.36% | +44.70% | 292B | |
| -1.45% | +3.48% | -24.87% | -39.22% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.26% | +4.79% | +25.99% | +53.59% | 370.01B | |
| Weighted average by Cap. | +1.40% | +5.21% | +41.84% | +81.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 179M 156M 144M 134M 254M 258M 1.73B 671M 8.36B 672M 658M 28.81B | 21.11B 222M 194M 178M 166M 315M 320M 2.14B 830M 10.35B 833M 814M 35.68B |
| Net income | -705M -7.4M -6.47M -5.94M -5.54M -10.5M -10.68M -71.52M -27.72M -346M -27.8M -27.19M -1.19B | 1.38B 14.45M 12.62M 11.59M 10.81M 20.49M 20.84M 140M 54.08M 675M 54.24M 53.06M 2.32B |
| Net Debt | 953M 10.01M 8.74M 8.03M 7.49M 14.19M 14.43M 96.67M 37.47M 467M 37.57M 36.76M 1.61B | 3.7B 38.89M 33.98M 31.2M 29.1M 55.16M 56.09M 376M 146M 1.82B 146M 143M 6.26B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | ₹459.85 | -0.77% | 2,137 |
| 02/07/26 | ₹463.40 | -2.21% | 3,956 |
| 01/07/26 | ₹473.85 | +2.03% | 16,644 |
| 30/06/26 | ₹464.40 | +2.43% | 10,673 |
| 29/06/26 | ₹453.40 | +4.86% | 20,985 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
